Cardiovascular pharmacogenetics /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Berlin ; New York :
Springer,
[2004]
|
| Series: | Handbook of experimental pharmacology ;
v. 160. |
| Subjects: |
Table of Contents:
- The role of genotyping in pharmacological therapy
- Pharmacogenetics and the treatment of cardiovascular disease
- Genetic polymorphisms and cardiovascular drug metabolism
- Genes that modify susceptability to atherosclerosis : targets for drug action
- Lipid-lowering responses modified by genetic variation
- The genetic basis of essential hypertension and its implication for treatment
- Genetic predisposition to cardiac hypertrophy
- Genetic determinants of susceptibility, prognosis and treatment in heart failure
- The genetics of cardiac channelopathies : implications for therapeutics
- Insulin resistance and cardiovascular disease : new insights from genetics
- Genetic disruption of nitric oxide synthases and cardiovascular disease : lessons from a candidate gene
- Association of thrombotic disease with genetic polymorphism of haemostatic genes : relevance to pharmacogenetics
- The influence of genetic factors on leukocyte and endothelial cell adhesion molecules
- Genetic regulation of metalloproteinase activity : pathogenic and therapeutic implications
- Current perspectives on gene and cell-based therapies for myocardial protection, rescue and repair